BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26842213)

  • 1. Discordant and aggressive tumor biology of solitary scalp metastasis amidst widespread skeletal metastases in differentiated thyroid carcinoma: Functional radionuclide and MR imaging features and clinical correlates.
    Basu S; Mahajan A
    Indian J Cancer; 2014; 51(4):613-4. PubMed ID: 26842213
    [No Abstract]   [Full Text] [Related]  

  • 2. F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid.
    Niederkohr RD; Dadras SS; Leavitt M; McDougall IR
    Clin Nucl Med; 2007 Feb; 32(2):162-4. PubMed ID: 17242580
    [No Abstract]   [Full Text] [Related]  

  • 3. A rare case of solitary subcutaneous scalp metastasis from follicular thyroid carcinoma revealed with positron emission tomography/computed tomography: a case report and review.
    Sager S; Yilmaz S; Doner RK; Niyazoglu M; Halac M; Kanmaz B
    J Cancer Res Ther; 2014; 10(2):431-3. PubMed ID: 25022416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
    Sarlis NJ; Gourgiotis L; Guthrie LC; Galen B; Skarulis MC; Shawker TH; Patronas NJ; Reynolds JC
    Clin Nucl Med; 2003 Mar; 28(3):208-17. PubMed ID: 12592128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous metastasis revealing a widely disseminated follicular thyroid carcinoma.
    Boughattas S; Hassine H; Chatti K; Jomaa R; Essabbah H
    Clin Nucl Med; 2002 May; 27(5):379-80. PubMed ID: 11953583
    [No Abstract]   [Full Text] [Related]  

  • 6. Unusual scalp metastasis from follicular thyroid carcinoma.
    Karabekir H; Polat C; Aktepe F; Gocmen-Mas N
    Saudi Med J; 2011 Aug; 32(8):849-51. PubMed ID: 21858396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
    Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
    J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiosarcoma of the scalp: extension study with PET-CT].
    Sopena P; Uruburu E; Abreu P; Giménez A; Martínez B; Martínez C
    Rev Esp Med Nucl; 2010; 29(2):91-2. PubMed ID: 20129715
    [No Abstract]   [Full Text] [Related]  

  • 9. Synchronicity.
    Mattern M; Gerard PS; Geller MD
    Am J Med; 2008 Oct; 121(10):868-9. PubMed ID: 18823857
    [No Abstract]   [Full Text] [Related]  

  • 10. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
    Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
    J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of iodine-123 whole-body scans in evaluating thyroid carcinoma and metastases.
    Yaakob W; Gordon L; Spicer KM; Nitke SJ
    J Nucl Med Technol; 1999 Dec; 27(4):279-81. PubMed ID: 10646545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
    Giraudet AL; Vanel D; Leboulleux S; Aupérin A; Dromain C; Chami L; Ny Tovo N; Lumbroso J; Lassau N; Bonniaud G; Hartl D; Travagli JP; Baudin E; Schlumberger M
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4185-90. PubMed ID: 17726071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nodule on the scalp as the first sign of extranodal disease in medullary thyroid carcinoma.
    Ferreres-Riera JR; Vinyals-Rioseco A; Penin-Mosquera RM; Servitje-Bedate O; Marcoval-Caus J; Mascaro-Galy JM; Puig-Sarda S; Macaya-Pascual A; Fabra-Fres A
    Dermatol Online J; 2017 May; 23(5):. PubMed ID: 28537865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of metastatic thyroid disease.
    Lee KY; Loré JM
    Otolaryngol Clin North Am; 1990 Jun; 23(3):475-93. PubMed ID: 1973282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent metastases of papillary thyroid carcinoma to the scalp and Meckel's cave.
    Phelan PS; Mull JL; Rajput MZ; Musiek AC
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29914897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Navigation-assisted localisation and resection of subclinical metastatic malignant melanoma of unknown primary based on 18-fluorodeoxyglcose positron emission tomography computed tomography fusion imaging.
    Ghazali N; Collyer JC; Tighe J
    Int J Oral Maxillofac Surg; 2012 Jan; 41(1):5-8. PubMed ID: 22024137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated solitary recurrent skull metastasis in papillary thyroid carcinoma.
    Naik D; Jebasingh FK; Prabhu K; Thomas N
    BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29700219
    [No Abstract]   [Full Text] [Related]  

  • 19. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
    Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R
    Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
    Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
    Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.